Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Moreno

Showing results (361-370 of 548) with videos related to

Pageof 55
Sort By:
Neuro-Oncology Advances|November 16, 2022
Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastomaMaria Vieito, Matteo Simonelli, Filip de Vos, et al.
Cancer|September 28, 2023
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomasShivaani Kummar, Lin Shen, David S Hong, et al.
Scientific Reports|March 9, 2021
Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain studyInés Gómez-Acebo, Trinidad Dierssen-Sotos, Mónica Mirones, et al.
Scientific Reports|July 28, 2019
Antibody responses to flagellin C and Streptococcus gallolyticus pilus proteins in colorectal cancerJulia Butt, Nerea Fernández de Larrea, Harold Tjalsma, et al.
Frontiers in Immunology|November 9, 2023
Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancerYa-Yu Tsai, Chenxu Qu, Joseph D Bonner, et al.
Gastroenterology|September 16, 2017
Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal CancerFernando Bellido, Nadine Sowada, Pilar Mur, et al.
Scientific Reports|April 18, 2025
Mendelian randomization study of sleep traits and risk of colorectal cancerOlympia Dimopoulou, Harriett Fuller, Rebecca C Richmond, et al.
JAMA Network Open|November 2, 2023
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled TrialThierry André, Dominique Berton, Giuseppe Curigliano, et al.
Nature Medicine|February 4, 2026
Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trialBenjamin Besse, Jessica J Lin, Lyudmila Bazhenova, et al.
International Journal of Cancer|July 18, 2018
Effect of mistimed eating patterns on breast and prostate cancer risk (MCC-Spain Study)Manolis Kogevinas, Ana Espinosa, Adela Castelló, et al.
Pageof 55

Showing results (361-370 of 548) with videos related to

Sort By:
Pageof 55
Neuro-Oncology Advances|November 16, 2022
Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastomaMaria Vieito, Matteo Simonelli, Filip de Vos, et al.
Cancer|September 28, 2023
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomasShivaani Kummar, Lin Shen, David S Hong, et al.
Scientific Reports|March 9, 2021
Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain studyInés Gómez-Acebo, Trinidad Dierssen-Sotos, Mónica Mirones, et al.
Scientific Reports|July 28, 2019
Antibody responses to flagellin C and Streptococcus gallolyticus pilus proteins in colorectal cancerJulia Butt, Nerea Fernández de Larrea, Harold Tjalsma, et al.
Frontiers in Immunology|November 9, 2023
Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancerYa-Yu Tsai, Chenxu Qu, Joseph D Bonner, et al.
Gastroenterology|September 16, 2017
Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal CancerFernando Bellido, Nadine Sowada, Pilar Mur, et al.
Scientific Reports|April 18, 2025
Mendelian randomization study of sleep traits and risk of colorectal cancerOlympia Dimopoulou, Harriett Fuller, Rebecca C Richmond, et al.
JAMA Network Open|November 2, 2023
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled TrialThierry André, Dominique Berton, Giuseppe Curigliano, et al.
Nature Medicine|February 4, 2026
Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trialBenjamin Besse, Jessica J Lin, Lyudmila Bazhenova, et al.
International Journal of Cancer|July 18, 2018
Effect of mistimed eating patterns on breast and prostate cancer risk (MCC-Spain Study)Manolis Kogevinas, Ana Espinosa, Adela Castelló, et al.
Pageof 55